title: Merck's protease inhibitor expanded access program now open.
authors.forename: T
authors.initials: T
authors.lastname: Smart
authors.forename: G
authors.initials: G
authors.lastname: Torres
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology; D018791:CD4 Lymphocyte Count; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015277:Hotlines; D006801:Humans; D019469:Indinavir; D018579:Patient Selection; D010593:Pharmaceutical Services / Q000458:organization & administration*; D011725:Pyridines / Q000627:therapeutic use*
chemical_list: D017320:HIV Protease Inhibitors; D011725:Pyridines; D019469:Indinavir